Nolvadex PCT (Tamoxifen Citrate)is a highly effective and safe (high-quality) SERM (selective estrogen receptor modulator) medication for breast cancer treatment. It is also used to treat gynecomastia (enlarged breasts in men) and male breast cancer in women. The main advantage of Nolvadex is that it can be taken in the morning or after breakfast.
Nolvadex is also used to treat androgenetic alopecia (a condition that affects both men and women). It can be taken daily or as a supplement.
It should only be used as directed by your doctor.
Nolvadex is a SERM (Selective Estrogen Receptor Modulator). It is used to treat breast cancer in women and men. It works by blocking the estrogen receptors in the body.
Nolvadex binds to estrogen receptors in the body, which helps to block estrogen from being absorbed into the bloodstream. This lowers the estrogen levels in the body and can reduce the risk of breast cancer.
It is most effective when used in combination with tamoxifen (Tamoxifen Tablet).
Nolvadex is available in the dosage strengths of 0.5 mg, 1 mg, 2 mg, and 5 mg. Your doctor may also adjust your dose if you have any liver or kidney problems, or if you are on other medications.
Like all medications, Nolvadex can cause side effects. Some of the more common side effects include:
If any of the above side effects persist or worsen, tell your doctor or pharmacist promptly.
You should also inform your doctor if you have any other medical conditions, especially:
If any of the above side effects seem to bother you, tell your doctor or pharmacist promptly.
In the case of any side effects of Nolvadex, do not stop taking it suddenly. Talk to your doctor if you experience any adverse reactions.
Inform your doctor if you are on any other medications, especially:
This information does not take the place of talking to your doctor about your medical condition. You and your doctor should talk about it together before deciding whether or not to have surgery. Talk about it openly.
Nolvadex (Tamoxifen Citrate) can be purchased by calling +1-888-704-0408 and talking with a customer service representative, or by placing an online order at liferxpharmacy.com. Customer Support is also aided by using the chat feature. For additional information, visit the "How to Order" page on liferxpharmacy.com.
Nolvadex (Tamoxifen Citrate) is a medication that can only be purchased with a doctors prescription. While processing your order for the medication, it is necessary to get a valid prescription from your doctor The prescription can be scanned, emailed, or uploaded at liferxpharmacy.com or fax on +1-800-986-4751 Alternatively, if you like, we can even contact your doctor to obtain a valid prescription.
The maximum amount of Nolvadex (Tamoxifen Citrate) can be ordered at one time is a 90-day supply. The amount that can be ordered is dependent on the instructions and quantity mentioned on your medical prescription. Refilling alternate is always available for future needs.
It is a completely safe and secure choice to order your medicine from us. We function similarly alike any other traditional pharmacy, intending to serve safe and affordable prescription medicines. Our associated pharmacists are functional in many countries and are completely licensed and certified.
Nolvadex (Tamoxifen Citrate) is available in both generic and brand form. Generic medicines contain the same active components as brand-name pharmaceuticals have. They ensure and meet the same quality, strength, and purity standards in comparison to any other brand.
Yes. We deliver all around the United States and other major countries.
LifeRx pharmacy makes it simple to refill your medication. By going to your accounts reorder section, you can easily place a refill option available online. You may examine your prior orders and choose which prescriptions order needs to be refilled. To order a refill, you can also call us and chat with one of our customer service representatives. Our live chat is also one of the convenient ways to reach out to us while placing a refill order.
We do not automatically refill prescriptions as it might be the case where you may no longer be taking the same medicines or your doctor may have revised your dose, among other things. However, we do offer a helpful refill reminder service. Based on your prescription history, we may call or email you to let you know when the ideal time is to place a refill order.
Hiroshiricia Graap Geertzen Sieren Nolvadex (Tamoxifen Citrate) Genericist Apotheke Interschnz Metformin MedExpress, M. A. K. Metzger Apotheke Interschnz MedExpress, M. D. Apotheke Interschnz MedExpress, M. Metzger Metzger MedHerxives M. Apotheke Interschnz MedHerxives M. Metzger Metzger Metzger MedHerxives M.The store will not work correctly in the case when cookies are disabled.
JavaScript seems to be disabled in your browser.For the best experience on our site, be sure to turn on Javascript in your browser.
Nolvadex (Tamoxifen) contains Tamoxifen which belongs to a group of medicines called selective estrogen receptor modulators (SERMs). These medicines work by reducing the effects of estrogen in men which leads to increased testosterone levels. This helps to reduce the risk of breast cancer and other hormonal conditions. Nolvadex is a popular choice for postmenopausal women due to its effectiveness and safety. Take Nolvadex as prescribed by your doctor. This will ensure that you get a optimum treatment response. Nolvadex is a reversible linker gene which can be used to link hormone-sensitive breast cancer to tamoxifen which is a selective estrogen receptor modulator (SERM). Nolvadex works by blocking estrogen receptors and reducing the effects of estrogen in the body. Nolvadex is a reversible linker gene which can be used to link hormone sensitive breast cancer to tamoxifen which is a selective estrogen receptor modulator (SERM) which lowers estrogen levels. Nolvadex is a minimally effective treatment for breast cancer including ER-negative early breast cancer, ER-positive breast cancer, ER-positive and hormone receptor positive advanced breast cancer.
Each film-coated tablet contains: Nolvadex 150mg, 5mg, 10mg, 15mg, and 20mg. Each film-coated tablet is engraved with Nolvadex (Tamox) in a similar language. For more information, including a description of this product, see our page.
Scripts/Frequently Asked QuestionsNolvadex is intended for women aged between 18 and 55 years of age who are at an increased risk of breast cancer (also known as early breast cancer) as determined by the National Library of Medicine. It is not intended to diagnose, treat, cure, or prevent any disease.
Nolvadex may also not be suitable in women with a history of breast cancer (a rare type of cancer that occurs in the breast tissue but is rarely detected in the blood), or women with a history of ovarian cancer, or women who have a history of blood clots or heart problems. It is important to tell your doctor about all other medications, including herbal supplements and vitamins, as they may interact with Nolvadex.
Nolvadex may not be suitable for some people with a history of blood clots, or heart problems such as angina, coronary artery disease, a history of heart attack, or stroke. This will ensure that you get the most effective treatment for your risk of blood clots or heart problems.
Nolvadex should not be used in the following cases:
Nolvadex (brand name Tamoxifen) is a widely used non-steroidal anti-estrogen agent (NSAID) for the treatment of breast cancer, particularly for postmenopausal women with advanced-stage disease. In the USA, nolvadex is used in combination with tamoxifen to reduce the risk of cardiovascular disease and endometrial cancer in postmenopausal women. To date, there is a lack of scientific data to support the benefits of nolvadex in lowering cardiovascular morbidity and mortality in postmenopausal women with advanced-stage breast cancer. However, recent studies have indicated that nolvadex was well tolerated in postmenopausal women with advanced-stage breast cancer. However, recent meta-analyses have shown no evidence of benefit for nolvadex in the reduction of cardiovascular mortality in postmenopausal women with advanced-stage breast cancer.
In this systematic review and meta-analysis, we assessed the beneficial effects of nolvadex in postmenopausal women with advanced-stage breast cancer, considering the combined use of tamoxifen and nolvadex. The primary objective of the review was to determine the effectiveness of nolvadex in the reduction of cardiovascular disease (CVD) and mortality in postmenopausal women with advanced-stage breast cancer. The search strategy was based on the Cochrane Database of Systematic Reviews (nRCTs) and systematic reviews (NOVATIS) databases. Two authors independently screened the studies for eligibility, independently assessed the risk of bias, and extracted data from included studies. The full search strategy was performed using the keywords. We performed the full-text review for all included studies. The primary outcome was the reduction in cardiovascular death and CVD from the primary outcome, and secondary outcomes included the risk of cardiovascular death and CVD from the secondary outcome. The quality of the included studies was low, with the following results: 4 studies were quality-controlled, 4 were observational, 3 were observational, and 3 were placebo-controlled. In the analysis of the outcomes, the Cochrane risk of bias assessment tool was used to assess the risk of bias. No serious limitations were identified for any outcome; the risk of bias was assessed independently by two authors, and no differences were reported between the two groups.
Of the studies, two studies assessed nolvadex use in postmenopausal women with advanced-stage breast cancer. One study assessed nolvadex use in combination with tamoxifen, while the other two investigated nolvadex use in combination with tamoxifen alone. In the latter study, postmenopausal women taking tamoxifen alone had a lower incidence of breast cancer than those taking nolvadex alone. In addition, the outcomes in the two studies were considered to be comparable. No additional biases were identified in the two studies, which did not report the effects of nolvadex. Our results suggest that nolvadex was well tolerated in postmenopausal women with advanced-stage breast cancer, although the benefits of nolvadex in reducing the risk of cardiovascular death and CVD were not established. However, our results are limited by the fact that few studies have demonstrated an effect of nolvadex on mortality in postmenopausal women with advanced-stage breast cancer, and this remains to be investigated.
We found no clear evidence that nolvadex was beneficial in reducing the risk of cardiovascular disease in postmenopausal women with advanced-stage breast cancer. Our results are based on two small-scale studies with small sample sizes, and it is unlikely that the results of these small-scale studies would translate into clinically meaningful results. However, our meta-analysis indicates that there is a lack of evidence to support the benefits of nolvadex in reducing the cardiovascular death and CVD in postmenopausal women with advanced-stage breast cancer. The benefits of nolvadex in reducing the risk of cardiovascular death and CVD in postmenopausal women with advanced-stage breast cancer are not established.
Citation:Mulston CA, et al. (2015) Effects of Nolvadex (brand name Tamoxifen) in Lowering Cardiovascular Disease Risk Among Postmenopausal Women With Advanced-Stage Breast Cancer. PLoS ONE 8(1): e0262021. https://doi.org/10.1371/journal.pone.0262021
Editor:David F.
Stade de France Pharmacy